骨质疏松症药物的依从性和持久性：文献综述。
Compliance and persistence with osteoporosis medications: a critical review of the literature.
机构信息
Cedars-Sinai/UCLA, 8641 Wilshire Blvd., Suite 301, Beverly Hills, CA 90211, USA.
出版信息
Rev Endocr Metab Disord. 2010 Dec;11(4):275-80. doi: 10.1007/s11154-010-9138-0.
Abstract
It is widely acknowledged that compliance and persistence with oral osteoporosis medications, particularly with bisphosphonates, is poor. Several excellent reviews have been written on compliance and persistence with osteoporosis medications and have discussed improvements seen with extended dosing intervals. This review begins with studies on extended dosing intervals to examine the limitations of administrative claims data. It also looks at compliance and persistence across multiple medical conditions, examining the importance of prescription fulfillment, intentional choice, causation and possible interventions.
摘要
人们普遍认为，口服骨质疏松症药物（尤其是双膦酸盐类药物）的依从性和持久性都很差。已经有几篇关于骨质疏松症药物的依从性和持久性的优秀综述，并讨论了延长给药间隔所带来的改善。这篇综述首先研究了延长给药间隔，以检查行政索赔数据的局限性。它还考察了多种医疗条件下的依从性和持久性，研究了处方兑现、有意选择、因果关系和可能的干预措施的重要性。
相似文献
1
Compliance and persistence with osteoporosis medications: a critical review of the literature.骨质疏松症药物的依从性和持久性：文献综述。
Rev Endocr Metab Disord. 2010 Dec;11(4):275-80. doi: 10.1007/s11154-010-9138-0.
2
Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review.真实世界中骨质疏松症患者口服双膦酸盐的持续性和依从性：系统评价。
BMJ Open. 2019 Apr 14;9(4):e027049. doi: 10.1136/bmjopen-2018-027049.
3
Oral bisphosphonate compliance and persistence: a matter of choice?口服双膦酸盐的依从性和持久性：一个选择的问题？
Osteoporos Int. 2011 Jan;22(1):21-6. doi: 10.1007/s00198-010-1274-6. Epub 2010 May 11.
4
Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.美国商业保险人群中女性骨质疏松症治疗的坚持和依从性。
J Manag Care Spec Pharm. 2015 Sep;21(9):824-33, 833a. doi: 10.18553/jmcp.2015.21.9.824.
5
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis.类风湿关节炎女性患者口服双膦酸盐治疗骨质疏松症的依从性和持续性。
BMC Musculoskelet Disord. 2017 Apr 11;18(1):152. doi: 10.1186/s12891-017-1514-4.
6
Interventions to improve osteoporosis medication adherence and persistence: a systematic review and literature appraisal by the ISPOR Medication Adherence & Persistence Special Interest Group.改善骨质疏松症药物依从性和持续性的干预措施：药物经济学与结果研究协会药物依从性与持续性特别兴趣小组的系统评价与文献评估
Osteoporos Int. 2013 Dec;24(12):2907-18. doi: 10.1007/s00198-013-2364-z. Epub 2013 May 1.
7
Persistence and compliance of medications used in the treatment of osteoporosis--analysis using a large scale, representative, longitudinal German database.骨质疏松症治疗用药的持续性和依从性——基于一个大规模、具有代表性的德国纵向数据库的分析
Int J Clin Pharmacol Ther. 2012 May;50(5):315-22. doi: 10.5414/cp201632.
8
Improving compliance and persistence with bisphosphonate therapy for osteoporosis.提高骨质疏松症双膦酸盐治疗的依从性和持续性。
Am J Med. 2006 Apr;119(4 Suppl 1):S18-24. doi: 10.1016/j.amjmed.2005.12.019.
9
A retrospective analysis of extended-interval dosing and the impact on bisphosphonate compliance in the US Military Health System.美国军事医疗体系中延长间隔给药的回顾性分析及其对双膦酸盐依从性的影响。
Osteoporos Int. 2012 Apr;23(4):1415-24. doi: 10.1007/s00198-011-1729-4. Epub 2011 Jul 23.
10
Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis.提高药物依从性的预测：以双膦酸盐治疗骨质疏松症为例。
Med Care. 2009 Mar;47(3):334-41. doi: 10.1097/MLR.0b013e31818afa1c.
引用本文的文献
1
Optimization of the dosage regimen of zoledronic acid with a kinetic-pharmacodynamic model and exposure-response analysis.用动力学-药效学模型和暴露-反应分析优化唑来膦酸的给药方案。
Front Pharmacol. 2023 Sep 27;14:1089774. doi: 10.3389/fphar.2023.1089774. eCollection 2023.
2
An overview of the management of osteoporosis in the aging female population.女性老年人群骨质疏松症的管理概述。
Womens Health (Lond). 2023 Jan-Dec;19:17455057231176655. doi: 10.1177/17455057231176655.
3
Effects of Teriparatide on Bone Mineral Density and Prevention of Fragility Fractures in Saudi Arabian Subjects with Osteoporosis: A Two-Year Clinical Study from a Single Center.特立帕肽对沙特骨质疏松症患者骨密度的影响及脆性骨折的预防：单中心为期两年的临床研究。
Int J Clin Pract. 2022 Oct 25;2022:3779745. doi: 10.1155/2022/3779745. eCollection 2022.
4
A High-Intensity Exercise Intervention Improves Older Women Lumbar Spine and Distal Tibia Bone Microstructure and Function: A 20-Week Randomized Controlled Trial.高强度运动干预改善老年女性腰椎和胫骨远端骨微结构及功能：一项为期20周的随机对照试验。
IEEE J Transl Eng Health Med. 2020 Jan 3;8:2100108. doi: 10.1109/JTEHM.2019.2963189. eCollection 2020.
5
Medication Decision-making in Osteoporosis: Can We Explain Why Patients Do Not Take Their Osteoporosis Medications?骨质疏松症药物治疗决策：我们能否解释患者为何不服用骨质疏松症药物？
Curr Osteoporos Rep. 2018 Dec;16(6):772-774. doi: 10.1007/s11914-018-0494-0.
6
A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D₃ Supplementation.一项比较维生素 D₃ 补充剂每月和每日给药的随机研究。
Nutrients. 2018 May 23;10(6):659. doi: 10.3390/nu10060659.
7
Melatonin-micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures.褪黑素-微量营养素治疗骨质减少症研究（MOTS）：一项转化研究，在一项为期一年的双盲随机对照试验后，评估褪黑素、锶（柠檬酸盐）、维生素D3和维生素K2（MK7）对绝经后骨质减少女性的骨密度、骨标志物周转率和健康相关生活质量的影响，以及对成骨细胞-破骨细胞共培养的影响。
Aging (Albany NY). 2017 Jan 26;9(1):256-285. doi: 10.18632/aging.101158.
8
Compliance and persistence with daily, weekly, and monthly bisphosphonates for osteoporosis in Japan: analysis of data from the CISA.日本骨质疏松症每日、每周和每月双膦酸盐的依从性和持久性：来自 CISA 的数据分析。
Arch Osteoporos. 2015;10:231. doi: 10.1007/s11657-015-0231-6. Epub 2015 Aug 22.
9
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods.一项IV期双臂随机交叉研究，比较在两个6个月期间每月一次服用维生素D3与每日服用固定剂量维生素D3和钙组合的依从性。
Osteoporos Int. 2015 Dec;26(12):2863-8. doi: 10.1007/s00198-015-3205-z. Epub 2015 Jun 23.
10
Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.用于评估钙代谢和骨代谢的生化标志物：在从药物制剂到营养产品的临床试验中的应用。
Nutr Res Rev. 2014 Dec;27(2):252-67. doi: 10.1017/S0954422414000183. Epub 2014 Nov 14.
本文引用的文献
1
Propensity score adjustment with multilevel data: setting your sites on decreasing selection bias.使用多级数据进行倾向得分调整：减少选择偏倚的站点设置
Ann Intern Med. 2010 Mar 16;152(6):393-5. doi: 10.7326/0003-4819-152-6-201003160-00010.
2
Patient and physician beliefs about control over health: association of symmetrical beliefs with medication regimen adherence.患者和医生对健康控制的信念：对称信念与药物治疗方案依从性的关联。
J Gen Intern Med. 2010 May;25(5):397-402. doi: 10.1007/s11606-010-1249-5. Epub 2010 Feb 20.
3
A clinical nurse specialist-led intervention to enhance medication adherence using the plan-do-check-act cycle for continuous self-improvement.一项由临床护理专家主导的干预措施，利用计划-执行-检查-行动循环来持续自我改进，以提高药物依从性。
Clin Nurse Spec. 2010 Mar-Apr;24(2):69-75. doi: 10.1097/NUR.0b013e3181cf554d.
4
Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.青光眼患者对降眼压治疗的有意和无意不依从。
Ophthalmology. 2010 May;117(5):903-8. doi: 10.1016/j.ophtha.2009.10.038. Epub 2010 Feb 13.
5
Primary medication non-adherence: analysis of 195,930 electronic prescriptions.主要药物不依从：195930 份电子处方分析。
J Gen Intern Med. 2010 Apr;25(4):284-90. doi: 10.1007/s11606-010-1253-9. Epub 2010 Feb 4.
6
Feasibility of using audio computer-assisted self-interview (ACASI) screening in routine HIV care.在常规艾滋病毒护理中使用音频计算机辅助自我访谈（ACASI）筛查的可行性。
AIDS Care. 2009 Aug;21(8):992-9. doi: 10.1080/09540120802657506.
7
Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option?埃塞俄比亚和乌干达关于坚持抗逆转录病毒治疗的观点：是选择问题还是根本没有选择？
AIDS Care. 2009 Nov;21(11):1381-7. doi: 10.1080/09540120902883119.
8
Shared treatment decision making improves adherence and outcomes in poorly controlled asthma.共同制定治疗决策可改善控制不佳的哮喘患者的依从性和结局。
Am J Respir Crit Care Med. 2010 Mar 15;181(6):566-77. doi: 10.1164/rccm.200906-0907OC. Epub 2009 Dec 17.
9
Depression as a risk factor for osteoporosis.抑郁症作为骨质疏松症的一个风险因素。
Trends Endocrinol Metab. 2009 Oct;20(8):367-73. doi: 10.1016/j.tem.2009.05.003. Epub 2009 Sep 9.
10
Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs.类风湿关节炎患者使用改善病情抗风湿药的依从率及其与不依从的关系。
J Rheumatol. 2009 Oct;36(10):2164-70. doi: 10.3899/jrheum.081204. Epub 2009 Sep 1.
Zotero 插件